Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM), a stock ValueWalk highlighted on Thursday for its Ebola treatments, is now trading down on the day after seeing significant gains Friday and Monday. Tekmira’s stock down on on FDA’s restrictions on its Ebola treatments Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM) is down $4.80 today, trading near $19 per share, after taking off on news regarding its Ebola treatments. After closing at $14.37 on Thursday, the stock rocketed to $20.70 on Friday and $23.80 on Monday. The stock took off Thursday after the close of trading on an FDA announcement that released restrictions on the firm’s…
Tekmira Pharmaceuticals Corporation Roller Coaster Jumps Then Drops
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.